Takeda's Dissident Holders Keep Trying to Kill Shire Deal

Bookmark
(Bloomberg) -- They have little chance of success, but the shareholder group trying to derail Takeda Pharmaceutical Co.’s $62 billion purchase of U.K.-listed Shire Plc is making last-minute attempt...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.